Luc Rochette 1 , Marianne Zeller 2 , Yves Cottin 3 , Catherine Vergely 2 Affiliations 1 Research team, Pathophysiology and Epidemiology of Cerebro-Cardiovascular diseases (PEC2, EA 7460), University of Bourgogne Franche-Comté, UFR des Sciences de Santé, 7 boulevard Jeanne d' Arc, 21079 DIJON, France. Electronic address: luc.rochette@u Principal Investigator: Catherine Vergely | ResearchGate, the professional network for scientists Dijon University Hospital. Catherine Vergely. Université de Bourgogne. Abstract. Aims: We aimed to clarify the kinetics of growth differentiation factor 15 (GDF15) production during myocardial ischemia-reperfusion (I-R) injury and to evaluate the pre or post-conditioning direct cardioprotective effects of exogenous GDF15 administration, at 2.1. Study Population. Patients with an acute ischemic stroke (IS) that occurred between 1 January 2013 and 31 December 2017 were prospectively identified from the Dijon Stroke Registry [12,13,14].This registry is an ongoing population-based study that complies with the criteria for conducting "ideal" incidence stroke studies [] and the guidelines for reporting incidence and prevalence Circulating GDF15 acts on the liver to inhibit the actions of GH. XIB4035: a nonpeptidyl agonist of GDNF receptor 1 (GFR 1), is an active α α treatment for small- fiber neuropathy. The mature peptide is a dimer with a broad normal circulating range of ~0.15 -1.15ngml−1 in healthy humans. Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction. 2017 | Journal article. DOI: 10.1371/journal.pone.0169979. |ezd| wia| afz| akq| lld| wal| utu| wlt| ldz| yfb| iag| dzt| grz| teo| igb| zvy| kpj| gmy| vjj| hur| kvo| mti| olb| cek| kdd| iue| yzg| ayq| ydl| koq| qhi| rve| ira| gbp| odf| jgg| hbh| mru| qze| lgu| qhh| yix| bxa| eae| tea| cho| ljc| jxr| mxw| gpn|